Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InspireMD (NSPR) EBT (2016 - 2025)

Historic EBT for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to -$13.1 million.

  • InspireMD's EBT fell 5423.07% to -$13.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$46.9 million, marking a year-over-year decrease of 5661.57%. This contributed to the annual value of -$31.9 million for FY2024, which is 6092.89% down from last year.
  • Latest data reveals that InspireMD reported EBT of -$13.1 million as of Q3 2025, which was down 5423.07% from -$13.0 million recorded in Q2 2025.
  • InspireMD's 5-year EBT high stood at -$3.2 million for Q1 2021, and its period low was -$13.1 million during Q3 2025.
  • Over the past 5 years, InspireMD's median EBT value was -$5.3 million (recorded in 2023), while the average stood at -$6.6 million.
  • Per our database at Business Quant, InspireMD's EBT plummeted by 8546.7% in 2021 and then soared by 223.16% in 2023.
  • InspireMD's EBT (Quarter) stood at -$4.1 million in 2021, then fell by 18.88% to -$4.8 million in 2022, then decreased by 20.57% to -$5.8 million in 2023, then plummeted by 61.28% to -$9.4 million in 2024, then tumbled by 39.33% to -$13.1 million in 2025.
  • Its EBT stands at -$13.1 million for Q3 2025, versus -$13.0 million for Q2 2025 and -$11.5 million for Q1 2025.